Breaking News, Collaborations & Alliances

GeneDesign Joins Ajinomoto Bio-Pharma Services

Opens oligonucleotide API development center

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GeneDesign, a wholly owned Ajinomoto company and provider of custom oligonucleotides for the biopharma industry, has joined Ajinomoto Bio-Pharma Services, becoming part of the contract development and manufacturing organization (CDMO).   The integration of GeneDesign’s services offerings with Aji Bio-Pharma’s small and large molecule capabilities in the U.S., Belgium and India strengthens the CDMO’s capabilities.   In addition, on April 5th, the company celebrated the grand opening o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters